The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Issue of Equity and Total Voting Rights

5 Sep 2018 11:50

RNS Number : 8619Z
Faroe Petroleum PLC
05 September 2018
 

5 September 2018

Faroe Petroleum plc

("Faroe Petroleum" or the "Company")

Issue of Equity and Total Voting Rights

On 30 August 2018, a former employee of the Company exercised nil-cost options over a total of 50,821 ordinary shares of 10p each in the share capital of the Company ("Ordinary Shares") under the Faroe Petroleum Incentive Plan ("FPIP").

 

Faroe Petroleum has applied to the London Stock Exchange for 50,821 new Ordinary Shares (the "New Ordinary Shares") to be admitted to trading on AIM ("Admission").

 

It is expected that Admission will become effective on 11 September 2018. The New Ordinary Shares will, following allotment, rank pari passu in all respects with the existing issued Ordinary Shares.

 

Following Admission, the Company's issued share capital will be 372,889,693 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. Therefore the total number of voting rights in the Company will be 372,889,693.

 

Shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

 

- Ends -

For further information please contact:

 

Faroe Petroleum plc

Graham Stewart/Jonathan Cooper

 

Tel: +44 1224 650 920

Stifel Nicolaus Europe Limited

Callum Stewart/Nicholas Rhodes/Ashton Clanfield

 

 

Tel: +44 207 710 7600

BMO Capital Markets

Tom Rider/ Jeremy Low

 

Tel: +44 207 236 1010

FTI Consulting

Ben Brewerton/Emerson Clarke

 

 

Tel: +44 207 831 3113

 

The information contained within this announcement is considered to be inside information prior to its release, as defined in Article 7 of the Market Abuse Regulation No. 596/2014, and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUGUWPBUPRGUA

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.